The FTSE's Cheapest Shares in the Storm

LONDON -- Looking at the FTSE 100's (INDEX: ^FTSE  ) cheapest shares on forward earnings often throws up some bargains.

As you might imagine, though, that wasn't the case over the past three months. At the end of February, I asked: "Which FTSE 100 shares have been left behind in the recent bull run?" Cue rolling tumbleweed.

I also said: "First quarter -- everyone's a winner." Again, I hold my hands up; they're all losers over the last quarter.

The humble P/E
Looking at the price-to-earnings ratio in isolation is a simple measure by design. In looking at the most basic of all valuation measures, we can quickly see any shares out of kilter with the market. In my opinion, the forecast P/E has merit as a starting point for further research, or possibly as a basis for mechanical trading. FTSE 100 companies are very heavily analyzed, but earnings are the main valuation metric, so it's interesting to watch how the stocks that are cheapest at face value move as macro sentiment shifts.

In February, all the stocks on the short list except AstraZeneca  (NYSE: AZN  ) were up on the previous quarter. The average improvement in the top 10 over the first couple of months was more than 13% (not including dividends), versus the FTSE 100's 5.5% improvement.

Since I ran the screen at the end of February, the average fall has been 22.3%, versus the FTSE's 11.3% drop. Here's how February's top 10 have performed.

Company

Opening Price, Feb. 27 (pence)

Closing Price, May 18 (pence)

Performance*

FTSE 100 Index N/A N/A (11.3%)
Kazakhmys 1,163 693.5 (39%)
Aviva  (NYSE: AV  ) 373.8 264.9 (25%)
BP  (NYSE: BP  ) 496.2 391.95 (20%)
Rio Tinto  (NYSE: RIO  ) 3,670.5 2,788 (22.5%)
AstraZeneca 2,856 2,621.5 (8%)
BAE Systems 316.9 271.8 (14%)
Eurasian Natural Resources 739 457.9 (38%)
Royal Dutch Shell 2,353 2,044 (12%)
BHP Billiton 2,073 1,704.5 (16%)
Barclays 247.6 176.1 (29%)

*Including dividends paid or owed since Feb. 27.

What's interesting about this table is that the companies that had the lowest forward P/Es three months ago have generally fallen the most. And almost all fared worse than the FTSE 100 index. Miners, financials (including insurers), and oil companies have borne the brunt of the storm.

Running the same screen now gives us the following top dozen:

Company

Closing Price, May 18

Forecast P/E 2013*

Aviva 264.9 4.62
Barclays 176.1 4.7
BP 391.95 5.54
Eurasian Natural Resources 457.9 5.83
Rio Tinto 2,788 6.13
Man Group 75.3 6.28
Glencore 345.35 6.3
RSA Insurance 98.7 6.4
Anglo American 2,019 6.49
BAE Systems 271.8 6.61
Xstrata 914.7 6.66
Royal Dutch Shell 2,044 6.7

Source: Morningstar. *Figures based on consensus broker forecasts for 2013 earnings per share.

And if we decided to make it a baker's dozen, we'd find February's No. 1, Kazakhmys, down to No. 13, despite its big fall. This, of course, is explained by brokers' falling forecasts.

So, putting BAE Systems to one side for the moment, it's all about financials, miners, and oil as fears over future earnings in these sectors weigh heaviest amidst eurozone worries. The top 12's average P/E has either improved or deteriorated -- depending on your investment philosophy -- from 7.8 to 6, despite brokers' earnings forecasts generally falling across the board. These are fearful times indeed.

So what will the next quarter bring? If you track the history of this experiment, you'll see how boomeranging sentiment causes huge gyrations. My best guess is that the next quarter will see sentiment shift for the better, but I'll try to let the numbers do the talking.

Finally, let me finish by adding that more share ideas can be found within this Motley Fool report: "8 Shares Held By Britain's Super Investor." The guide reviews the investing approach and portfolio of City dividend legend Neil Woodford, and it's free to download today.

Are you looking to profit from this uncertain economy? "10 Steps To Making A Million In The Market" is The Motley Fool's latest report. We urge you to read it today -- your wealth could be transformed. Click here now to request your free, no-obligation copy. The Motley Fool is helping Britain invest. Better.

Further investment opportunities:

David owns shares in Aviva, BP, AstraZeneca, Barclays, RSA Insurance, and Royal Dutch Shell. The Motley Fool has a disclosure policy. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. Try any of our Foolish newsletter services free for 30 days.


Read/Post Comments (0) | Recommend This Article (7)

Comments from our Foolish Readers

Help us keep this a respectfully Foolish area! This is a place for our readers to discuss, debate, and learn more about the Foolish investing topic you read about above. Help us keep it clean and safe. If you believe a comment is abusive or otherwise violates our Fool's Rules, please report it via the Report this Comment Report this Comment icon found on every comment.

Be the first one to comment on this article.

Sponsored Links

Leaked: Apple's Next Smart Device
(Warning, it may shock you)
The secret is out... experts are predicting 458 million of these types of devices will be sold per year. 1 hyper-growth company stands to rake in maximum profit - and it's NOT Apple. Show me Apple's new smart gizmo!

DocumentId: 1891662, ~/Articles/ArticleHandler.aspx, 9/2/2014 7:44:29 PM

Report This Comment

Use this area to report a comment that you believe is in violation of the community guidelines. Our team will review the entry and take any appropriate action.

Sending report...


Advertisement